These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 15501014
1. Immunomodulating effect of influenza vaccination in the elderly differing in health status. Myśliwska J, Trzonkowski P, Szmit E, Brydak LB, Machała M, Myśliwski A. Exp Gerontol; 2004 Oct; 39(10):1447-58. PubMed ID: 15501014 [Abstract] [Full Text] [Related]
2. [The role of anti-influenza vaccination in elderly persons]. Myśliwska J. Przegl Epidemiol; 2002 Oct; 56 Suppl 1():91-9. PubMed ID: 12194236 [Abstract] [Full Text] [Related]
3. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Müller D, Szucs TD. Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730 [Abstract] [Full Text] [Related]
4. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Vaccine; 2006 Nov 10; 24(44-46):6620-3. PubMed ID: 16870313 [Abstract] [Full Text] [Related]
5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep 10; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
6. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home. Iorio AM, Neri M, Lepri E, Camilloni B, Basileo M, Sigismondi N, Fabiani C, Calzoletti L, Puzelli S, Donatelli I. Vaccine; 2006 Nov 10; 24(44-46):6615-9. PubMed ID: 16828941 [Abstract] [Full Text] [Related]
7. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Szucs TD, Müller D. Vaccine; 2005 Oct 17; 23(43):5055-63. PubMed ID: 16046035 [Abstract] [Full Text] [Related]
8. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. Blank PR, Schwenkglenks M, Szucs TD. J Infect; 2009 Jun 17; 58(6):446-58. PubMed ID: 19446340 [Abstract] [Full Text] [Related]
9. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks. Buxton JA, Skowronski DM, Ng H, Marion SA, Li Y, King A, Hockin J. J Infect Dis; 2001 Jul 15; 184(2):188-91. PubMed ID: 11424016 [Abstract] [Full Text] [Related]
10. White blood cell telomerase activity and incident respiratory illness among community-dwelling elderly vaccinated against seasonal influenza. Targonski PV, Caldwell CR, Strausbauch M, Wettstein P, Poland GA, Tangalos EG. Clin Pharmacol Ther; 2007 Dec 15; 82(6):694-9. PubMed ID: 17971815 [Abstract] [Full Text] [Related]
11. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China. Zhu FC, Zhou W, Pan H, Lu L, Gerez L, Nauta J, Giezeman K, de Bruijn I. Vaccine; 2008 Aug 18; 26(35):4579-84. PubMed ID: 18602729 [Abstract] [Full Text] [Related]
12. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W. Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661 [Abstract] [Full Text] [Related]
13. Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults. Leroux-Roels I, Van der Wielen M, Kafeja F, Vandermeulen C, Lazarus R, Snape MD, John T, Carre C, Nougarede N, Pepin S, Leroux-Roels G, Hoppenbrouwers K, Pollard AJ, Van Damme P. Vaccine; 2009 Nov 16; 27(49):6918-25. PubMed ID: 19761837 [Abstract] [Full Text] [Related]
14. [Study on the effectiveness and cost-benefit of influenza vaccine on elderly population in Beijing city]. Liu M, Liu GF, Wang Y, Zhao W, Wang L, Shi W, Wen SY. Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun 16; 26(6):412-6. PubMed ID: 16185449 [Abstract] [Full Text] [Related]
15. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]
16. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M. J Infect Dis; 2008 Sep 01; 198(5):650-8. PubMed ID: 18652550 [Abstract] [Full Text] [Related]
17. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers. de Bruijn IA, Nauta J, Gerez L, Palache AM. Virus Res; 2004 Jul 01; 103(1-2):139-45. PubMed ID: 15163502 [Abstract] [Full Text] [Related]
18. [Effectiveness of influenza vaccination in healthy adults--a fourfold decrease in influenza morbidity during one influenza season]. Chlíbek R, Beran J, Splino M. Epidemiol Mikrobiol Imunol; 2002 Apr 01; 51(2):47-51. PubMed ID: 11987579 [Abstract] [Full Text] [Related]
19. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F, Perego A, Zanetti AR. J Med Virol; 2007 Aug 01; 79(8):1176-9. PubMed ID: 17596830 [Abstract] [Full Text] [Related]
20. A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia. Morales A, Arias Salazar J, Salazar Y, García A, Arnoux S, Arancibia A, Deroche C, Rey E. Medicina (B Aires); 2003 Aug 01; 63(3):197-204. PubMed ID: 12876902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]